JIC
WHWK

Johnson Investment Counsel’s Whitehawk Therapeutics WHWK Stock Holding History

Johnson Investment Counsel’s Portfolio WHWK Stock Details WHWK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-21,369
Closed -$542K – 670
2021
Q2 		$542K Hold
21,369
– – 0.01% 425
2021
Q1 		$413K Hold
21,369
– – 0.01% 452
2020
Q4 		$314K Hold
21,369
– – 0.01% 487
2020
Q3 		$481K Hold
21,369
– – 0.01% 393
2020
Q2 		$401K Buy
+21,369
New +$280K 0.01% 419
2020
Q1 		– Sell
-21,369
Closed -$200K – 618
2019
Q4 		$200K Hold
21,369
– – ﹤0.01% 579
2019
Q3 		$218K Buy
+21,369
New +$237K ﹤0.01% 559

Other funds holding WHWK

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AIM
Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Johnson Investment Counsel's WHWK Position: Q3 2021 in Review

Johnson Investment Counsel sold out of Whitehawk Therapeutics (WHWK) in Q3 2021, closing a stake of 21,369 shares — an estimated $542K sold.

Johnson Investment Counsel first reported a position in WHWK in Q3 2019 and held it in 7 quarters. The position peaked at $542K in Q2 2021. 33 funds tracked by Wall St. Rank hold WHWK as of Q3 2021.

  • Johnson Investment Counsel reported no remaining Whitehawk Therapeutics position as of Q3 2021 after selling out during the quarter.
  • Johnson Investment Counsel sold 21,369 Whitehawk Therapeutics shares in Q3 2021, an estimated $542K.
  • Johnson Investment Counsel first reported a position in Whitehawk Therapeutics in Q3 2019 and held it in 7 quarters.
  • Johnson Investment Counsel's Whitehawk Therapeutics position peaked at $542K in Q2 2021.
  • 33 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q3 2021.

Based on Johnson Investment Counsel's 13F filing for Q3 2021, filed 12 Nov 2021.